Tag:
IK-1001
Latest Headlines
Latest Headlines
Ikaria plots $200M IPO
Undaunted by the lower-than-expected debuts of other biotech IPOs, Ikaria has filed for a $200 million IPO. The New Jersey-based company, which also has R&D operations in Seattle, plans to trade
